Vanguard Explorer Fund Investor Shares (VEXPX) Dividend Yield, History & Forecast

Vanguard Explorer Fund Investor Shares (VEXPX) is an exchange-traded fund (ETF) listed on the NASDAQ. It pays a current dividend yield of 6.46% ($8.48 per share annually (TTM)). The most recent ex-dividend date was December 23, 2025, with payment scheduled for December 24, 2025. market capitalization is approximately $23.25B.

Loading quote...

VEXPX fund composition

VEXPX holds 100 positions, with 8.1% of assets in its ten largest.

Top 10 holdings

HoldingWeight
MTSIMACOM Technology Solutions Holdings Inc1.31%
VBVanguard Small-Cap ETF1.01%
LSCCLattice Semiconductor Corp0.94%
RBCRBC Bearings Inc0.82%
BWXTBWX Technologies Inc0.78%
PRPermian Resources Corp0.68%
MEDPMedpace Holdings Inc0.66%
GWREGuidewire Software Inc0.66%
WTFCWintrust Financial Corp0.65%
DOCNDigitalOcean Holdings Inc0.63%

Frequently Asked Questions about Vanguard Explorer Fund Investor Shares (VEXPX)

What is Vanguard Explorer Fund Investor Shares's dividend yield?
Vanguard Explorer Fund Investor Shares (VEXPX) pays a current trailing twelve-month dividend yield of 6.46%, which works out to $8.48 per share annually based on the most recent payout schedule.
When does Vanguard Explorer Fund Investor Shares pay its next dividend?
The most recent ex-dividend date was December 23, 2025. The next scheduled dividend payment date is December 24, 2025.
How many years has Vanguard Explorer Fund Investor Shares increased its dividend?
Vanguard Explorer Fund Investor Shares (VEXPX) has increased its dividend for 1 consecutive year.
Is Vanguard Explorer Fund Investor Shares a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. Vanguard Explorer Fund Investor Shares (VEXPX) currently has 1 year of consecutive increases.
What sector is Vanguard Explorer Fund Investor Shares in?
Vanguard Explorer Fund Investor Shares (VEXPX) operates in the Financial Services sector, specifically the Asset Management industry.